Genomic alterations of KEAP1/NFE2L2/CUL3(K/N/C) in Chinese lung cancer patients (pts)

被引：0
|
作者：
Qian, C. [1 ]
Wang, C. [2 ]
Wang, X. [2 ]
He, Q. [2 ]
Ma, T. [2 ]
Zhang, X. [2 ]
机构：
[1] Peoples Liberat Army Mil Med Univ, Affiliated Hosp 3, Daping Hosp, Dept Oncol, Chongqing, Peoples R China
[2] Genetron Hlth Beijing Co Ltd, Dept Translat Med, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002P
引用
收藏
页码：S1118 / S1118
页数：1
相关论文
共 50 条
  • [21] Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
    Siedlinski, Mateusz
    Postma, Dirkje S.
    Boer, Jolanda M. A.
    van der Steege, Gerrit
    Schouten, Jan P.
    Smit, Henriette A.
    Boezen, H. Marike
    RESPIRATORY RESEARCH, 2009, 10
  • [22] Genetic landscape of KEAP1 and NFE2L2 mutated cancers from the AACR GENIE database
    Zaki, M.
    Pahalyants, V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] NFE2L2 gene mutation in Japanese lung cancer patients
    Sasaki, Hidefumi
    Hikosaka, Yu
    Kawano, Osamu
    Okuda, Katsuhiro
    Moriyama, Satoru
    Yano, Motoki
    Fujii, Yoshitaka
    CANCER RESEARCH, 2010, 70
  • [24] Impact of KEAP1/NFE2L2 Mutations on Local Recurrence in Patients Receiving Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases
    Chen, M. S.
    Carpenter, D. J.
    Leng, J. X.
    Qazi, J. J.
    Wan, Z.
    Niedzwiecki, D.
    Alder, L. R.
    Clarke, J.
    Kirkpatrick, J. P.
    Floyd, S. R.
    Reitman, Z. J.
    Mullikin, T. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E223 - E223
  • [25] NFE2L2 gene mutation in Japanese lung cancer patients
    Sasaki, Hidefumi
    Hikosaka, Yu
    Kawano, Osamu
    Okuda, Katsuhiro
    Moriyama, Satoru
    Yano, Motoki
    Fujii, Yoshitaka
    CANCER RESEARCH, 2010, 70
  • [26] Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
    Yang, Xiaodong
    Li, Ming
    Chen, Zhencong
    Fan, Xiaobin
    Guo, Liang
    Jin, Bo
    Huang, Yiwei
    Wang, Qun
    Wu, Liang
    Zhan, Cheng
    JOURNAL OF CANCER, 2022, 13 (05): : 1512 - 1522
  • [27] KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer.
    Binkley, Michael S.
    Jeon, Young-Jun
    Nesselbush, Monica
    Moding, Everett J.
    Nabet, Barzin
    Almanza, Diego S.
    Yoo, Christopher
    Kurtz, David Matthew
    Owen, Susie Grant
    Backhus, Leah Monique
    Berry, Mark F.
    Shrager, Joseph B.
    Ramchandran, Kavitha
    Padda, Sukhmani Kaur
    Das, Millie
    Neal, Joel W.
    Wakelee, Heather A.
    Alizadeh, Ash A.
    Loo, Billy W.
    Diehn, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
    Paik, Paul K.
    Fan, Pang-Dian
    Qeriqi, Besnik
    Namakydoust, Azadeh
    Daly, Bobby
    Ahn, Linda
    Kim, Rachel
    Plodkowski, Andrew
    Ni, Ai
    Chang, Jason
    Fanaroff, Rachel
    Ladanyi, Marc
    de Stanchina, Elisa
    Rudin, Charles M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : 516 - 526
  • [29] Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228.
    Paik, Paul K.
    Ahn, Linda Su Hyun
    Ginsberg, Michelle S.
    Plodkowski, Andrew J.
    Kim, Rachel
    Doyle, L. Austin
    Rudin, Charles M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] KEAP1/NFE2L2 Transcriptomic Signature Predicts Survival in Advanced Stage NSCLC Patients Without Actionable Driver Mutations
    Scheffler, M.
    Dugan, M.
    Saleh, M. M.
    Koleczko, S.
    Bragelmann, J.
    Arolt, C.
    Nogova, L.
    Riedel, R.
    Michels, S.
    Eisert, A.
    Fischer, R.
    Scharpenseel, H.
    Weber, J. P.
    Scheel, A. H.
    Merkelbach-Bruse, S.
    Buttner, R.
    Lafleur, F.
    Wild, R.
    Catanzariti, L.
    Hillmer, A. M.
    Wolf, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S451 - S452
12345